Refused Program Extension. If (a) Vertex proposes a Research Program Extension under Section 2.9 hereof which is a “Qualifying Extension Proposal” as defined below: and
Appears in 4 contracts
Samples: Research, Development and Commecialization Agreement (Vertex Pharmaceuticals Inc / Ma), Development and Commecialization Agreement (Royalty Pharma PLC), Development and Commecialization Agreement (Royalty Pharma PLC)
Refused Program Extension. If (a) Vertex proposes a Research Program Extension under Section 2.9 hereof which is a “Qualifying Extension Proposal” as defined below: andand Information redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been separately filed with the Commission.
Appears in 2 contracts
Samples: Confidential Treatment Requested (Vertex Pharmaceuticals Inc / Ma), Confidential Treatment Requested (Vertex Pharmaceuticals Inc / Ma)
Refused Program Extension. If (a) Vertex proposes a Research Program Extension under Section 2.9 hereof which is a “"Qualifying Extension Proposal” " as defined below: and
Appears in 1 contract
Samples: Development and Commecialization Agreement (Vertex Pharmaceuticals Inc / Ma)
